Nizatidine and cisapride increase salivary secretion in rats

Digestive Diseases and Sciences

Volumn 49, Issue 3, 2004, Pages 399-403

  Adachi, Kyoichi ^a   Furuta, Kenji ^a   Katsube, Tomoko ^a   Fujisawa, Tomoo ^a   Azumi, Takane ^a   Fujishiro, Hirofumi ^a   Ishihara, Shunji ^a   Amano, Yuji ^a   Kinoshita, Yoshikazu ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Cisapride; Famotidine; Nizatidine; Rat; Salivary secretion

Indexed keywords

CISAPRIDE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; NIZATIDINE; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; GASTROESOPHAGEAL REFLUX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SALIVARY GLAND; SALIVATION; STOMACH ACID SECRETION;

ANIMALS; CISAPRIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; MALE; NIZATIDINE; RATS; RATS, SPRAGUE-DAWLEY; SALIVATION; SEROTONIN AGONISTS;

EID: 1842451800     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:DDAS.0000020492.16088.28     Document Type: Article

References (27)

1. Dodds WJ, Hogan WJ, Helm JF, Dent J: Pathogenesis of reflux esophagitis. Gastroenterology 81:376-394, 1981
2. Sonnenberg A, Steinkamp U, Weise A, Berges W, Wienbeck M, Rohner HG, Peter P. Salivary secretion in reflux esophagitis. Gastroenterology 83:889-395, 1982
3. Helm JF, Dodds WJ, Hogan WJ, Soergel KH, Egide MS, Wood CM: Acid neutralizing capacity of human saliva. Gastroenterology 83:69-74, 1982
4. Helm JF, Dodds WJ, Pelc LR, Palmer DW, Hogan WJ, Teeter BC: Effect of esophageal emptying and saliva on clearance of acid from the esophagus. N Engl J Med 310:284-288, 1984
5. Helm JF, Dodds WJ, Hogan WJ: Salivary response to esophageal acid in normal subjects and patients with reflux esophagitis. Gastroenterology 93:1393-1397, 1987
6. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A: Chronic xerostomia increases esophageal acid exposure and is associated with esophageal injury. Am J Med 90:701-706, 1991
7. Kao CH, Ho YJ, ChangLai SP, Liao KK: Evidence for decreased salivary function in patients with reflux esophagilis. Digestion 60:191-195, 1999
8. Mangos JA, McSherry NR, Nousia-Arvanitakis S, Irwin K: Handling of water and electrolytes by rabbit parotid and submaxillary glands. Am J Physiol 225:450-455, 1973
9. Beal AM: Parotid salivary flow and composition during infusion of acetylcholine and atropine into the carotid artery of conscious sodium-replete sheep. Q J Exp Physiol 64:89-107, 1979
10. Beal AM: Electrolyte composition of parotid saliva from sodium-replete red kangaroos (Macropus rufus). J Exp Biol 111:225-237, 1984
11. 2-receptor antagonist nizatidine. J Pharmacobio-Dyn 11:767-771, 1988
12. 2- receptor antagonist, and its possible mechanism of action in dogs and rats. J Pharmacol Exp Ther 264:152-157, 1993
13. Ueki S, Matsunaga Y, Yoneta T, Tamaki H, Itoh Z: Gastroprokinetic activity of nizatidine during the digestive state in the dog and rat. Arzneim-Forsch/Drug Res 49(II):618-625, 1999
14. Neya T, Itano N, Mizutani M, Yamasato T, Takaki M, Nakayama S: The effect of cisapride on neural 5-HT receptors in guinea-pig isolated ileum. Eur J Pharmacol 106:221-222, 1984
15. Tonini M, Galligan JJ, North RA: Effects of cisapride on cholinergic neurotransmission and propulsive motilily in the guinea pig ileum. Gastroenterology 96:1257-1264, 1989
16. Van den Brink HW, Schuurkes JA, Van Nueten JM, Van Rossum JM: R 50 595, a selective non-competitive antagonist of cisapride, BRL 24924 and 5-hydroxytryptamine on the guinea-pig ileum. Eur J Pharmacol 181:119-125, 1990
17. Craig DA, Clarke DE: Pharmacological characterization of a neuronal receptor for 5-hydroxytryptamine in guinea pig ileum with properties similar to the 5-hydroxytryptamine receptor. J Pharmacol Exp Ther 252:1378-1386, 1990
18. Taniyama K, Nakayama S, Takeda K, Matsuyama S, Shirakawa J, Sano I, Tanaka C: Cisapride stimulates motility of the intestine via the 5-hydroxytryptamine receptors. J Pharmacol Exp Ther 258:1098-1104, 1991
19. Adachi K, Ono M, Kawamura A, Yuki M, Fujishiro H, Kinoshita Y: Nizatidine and cisapride enhance salivary secretion in humans. Aliment Pharmacol Ther 16:297-301, 2002
20. Hiramatsu Y, Okabe S: Effect of intraduodenally administered hislamine on gastric acid secretion in rats and guinea pigs. Dig Dis Sci 39:689-697, 1994
21. Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NA, Raymond F, Olausson M, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239-351, 1987
22. Ruth M, Enbom H, Lundell L, Lonroth H, Sandberg N, Sandmark, S: The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis. Scand J Gastroenterol 23:1141-1146, 1988
23. Bate CM, Keeling PW, O'Morain C, Wilkinson SP, Foster DN, Mountford RA, Temperley JM, Harvey RF, Thompson DG, Davis M, et al.: Comparison of omeprazole and cimetidine in reflux oesophatis: symptomatic, endoscopic, and histological evaluations. Gut 31:968-972, 1990
24. Chiba N, De Gara CJ, Wilkinson JM, Hunt RH: Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: A meta-analysis. Gastroenterology 112:1798-1810, 1997
25. Vigneri S, Termini R, Leandro G, Badalamenti S, Pantalena M, Savarino V, Di Mario F, Battaglia G, Mela GS, Pilotto A, et al.: A comparison of five maintenance therapies for reflux esophagitis. N Engl J Med 333:1106-1110, 1995
26. Inauen W, Emde C, Weber B, Armstrong D, Bettschen HU, Huber T, Scheurer U, Blum AL, Halter F, Merki HS: Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: A 24 hour ambulatory combined pH and manometry study. Gut 34:1025-1031, 1993
27. Goldin GF, Marcinkiewicz M, Zbroch T, Bityutskiy LP, McCallum RW, Sarosiek J: Esophagoprotective potential of cisapride. An additional benefit for gastroesophageal reflux disease. Dig Dis Sci 42:1362-1369, 1997